Breaking the Code: How Genome Sequencing Is Revolutionizing the Diagnosis of Rare Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Genetics and Genomics".
Deadline for manuscript submissions: 6 November 2025 | Viewed by 144
Special Issue Editors
Interests: human genetics and genomics; bioinformatics; cytogenetics and cytogenomics
Special Issue Information
Dear Colleagues,
Recent advances in genomic sequencing are transforming rare disease diagnosis and comprehension, giving patients and their families new hope around the world.
More than 300 million people worldwide are affected by uncommon diseases, many of which are genetically based. Accurate and prompt diagnosis is still a major obstacle. Whole genome sequencing (WGS), next-generation sequencing (NGS), and other advanced genomic technologies have made it possible to identify disease-causing gene variations more quickly and accurately, opening the door to more targeted therapies and enhanced clinical outcomes.
Original research and reviews examining the most recent developments in rare disease genome sequencing are requested for this Special Issue. We are looking for submissions on a variety of subjects, such as new diagnostic techniques, developments in bioinformatics, and the practical implications of genomic results.
This Special Issue aims to highlight the revolutionary potential of genome sequencing in rare disease research and patient treatment by bringing together a variety of viewpoints from genetics, bioinformatics, and clinical practice.
Dr. Massimiliano Chetta
Prof. Dr. Nenad Bukvic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genomics
- bioinformatics
- genetics
- cytogenetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
